Aortitis

Circulation

Volumn 117, Issue 23, 2008, Pages 3039-3051

  Gornik, Heather L ^a,b   Creager, Mark A ^c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Aortic aneurysm; Aortitis; Giant cell arteritis; Takayasu arteritis; Vasculitis

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; C REACTIVE PROTEIN; FLUORODEOXYGLUCOSE F 18; HLA B27 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ABDOMINAL AORTA ANEURYSM; ABDOMINAL PAIN; ACUTE CORONARY SYNDROME; ADD ON THERAPY; ANCA ASSOCIATED VASCULITIS; ANEURYSM SURGERY; ANTIBIOTIC THERAPY; AORTA ARCH SYNDROME; AORTA DISSECTION; AORTA THROMBOSIS; AORTA VALVE REGURGITATION; AORTITIS; AORTOGRAPHY; BACKACHE; BACTERIAL INFECTION; BEHCET DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COGAN SYNDROME; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTRAST ENHANCEMENT; CORONARY ARTERY BYPASS GRAFT; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; ECHOGRAPHY; ENDOVASCULAR SURGERY; FEVER; GIANT CELL ARTERITIS; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INTERMITTENT CLAUDICATION; INVASIVE PROCEDURE; LABORATORY TEST; MAGNETIC RESONANCE ANGIOGRAPHY; MYCOBACTERIUM TUBERCULOSIS; NON INVASIVE PROCEDURE; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PLASTIC SURGERY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; RHEUMATOID ARTHRITIS; SALMONELLA; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; SPONDYLOARTHROPATHY; STABLE ANGINA PECTORIS; STAPHYLOCOCCUS; STEROID THERAPY; STREPTOCOCCUS PNEUMONIAE; SYSTEMIC LUPUS ERYTHEMATOSUS; THORACIC AORTA ANEURYSM; TREATMENT DURATION; TREATMENT OUTCOME; TUBERCULOSIS;

AORTITIS; HUMANS;

EID: 46449124590     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.760686     Document Type: Review

References (128)

1. Foote EA. Postier RG. Greenfield RA. Bronze MS. Infectious aortitis. Curr Treat Options Cardiovasc Med. 2005;7:89-97.
2. Virmani R. Burke A. Nonatherosclerotic diseases of the aorta and miscellaneous disease of the main pulmonary arteries and large veins. In: Silver M. Gotlieb A. Schoen F. eds. Cardiovascular Pathology. 3rd ed. Philadelphia. Pa: Churchill Livingstone; 2001:107-137.
3. Gravanis MB. Giant cell arteritis and Takayasu aortitis: morphologic. pathogenetic and etiologic factors. Int J Cardiol. 2000;75(suppl 1): S21-S33.
4. Tavora F. Burke A. Review of isolated ascending aortitis: differential diagnosis. including syphilitic. Takayasu's and giant cell aortitis. Pathology. 2006;38:302-308.
5. Miller DV. Isotalo PA. Weyand CM. Edwards WD. Aubry MC. Tazelaar HD. Surgical pathology of noninfectious ascending aortitis: a study of 45 cases with emphasis on an isolated variant. Am J Surg Pathol. 2006;30:1150-1158.
6. Moriuchi J. Wakisaka A. Aizawa M. Yasuda K. Yokota A. Tanabe T. Itakura K. HLA-linked susceptibility gene of Takayasu disease. Hum Immunol. 1982;4:87-91.
7. Volkman DJ. Mann DL. Fauci AS. Association between Takayasu's arteritis and a B-cell alloantigen in North Americans. N Engl J Med. 1982;306:464-465.
8. Khraishi MM. Gladman DD. Dagenais P. Fam AG. Keystone EC. HLA antigens in North American patients with Takayasu arteritis. Arthritis Rheum. 1992;35:573-575.
9. Guard RW. Gotis-Graham I. Edmonds JP. Thomas AC. Aortitis with dissection complicating systemic lupus erythematosus. Pathology. 1995; 27:224-228.
10. Chirinos JA. Tamariz LJ. Lopes G. Del Carpio F. Zhang X. Milikowski C. Lichtstein DM. Large vessel involvement in ANCA-associated vas-culitides: report of a case and review of the literature. Clin Rheumatol. 2004;23:152-159.
11. Sakane T. Takeno M. Suzuki N. Inaba G. Behcet's disease. N Engl J Med. 1999;341:1284-1291.
12. Nakamura Y. Ogino H. Matsuda H. Minatoya K. Sasaki H. Kitamura S. Multiple and repetitive anastomotic pseudoaneurysms with polyarteritis nodosa. Ann Thorac Surg. 2008;85:317-319.
13. Hosoda Y. Iri H. Hata J. Wakasugi A. Granulomatous aortitis associated with necrotizing angiitis and glomerulonephritis. Acta Pathol Jpn. 1973; 23:129-138.
14. Morgan SH. Asherson RA. Hughes GR. Distal aortitis complicating Reiter's syndrome. Br Heart J. 1984;52:115-116.
15. Lautermann D. Braun J. Ankylosing spondylitis: cardiac manifestations. Clin Exp Rheumatol. 2002;20:S11-S15.
16. Weiler V. Redtenbacher S. Bancher C. Fischer MB. Smolen JS. Concurrence of sarcoidosis and aortitis: case report and review of the literature. Ann Rheum Dis. 2000;59:850-853.
17. Haynes BF. Kaiser-Kupfer MI. Mason P. Fauci AS. Cogan syndrome: studies in thirteen patients. long-term follow-up. and a review of the literature. Medicine (Baltimore). 1980;59:426-441.
18. Hellmann DB. Grand DJ. Freischlag JA. Inflammatory abdominal aortic aneurysm. JAMA. 2007;297:395-400.
19. Vaglio A. Buzio C. Chronic periaortitis: a spectrum of diseases. Curr Opin Rheumatol. 2005;17:34-40.
20. Jois RN. Gaffney K. Marshall T. Scott DG. Chronic periaortitis. Rheumatology (Oxford). 2004;43:1441-1446.
21. Kuwana M. Wakino S. Yoshida T. Homma M. Retroperitoneal fibrosis associated with aortitis. Arthritis Rheum. 1992;35:1245-1247.
22. Tang T. Boyle JR. Dixon AK. Varty K. Inflammatory abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2005;29:353-362.
23. Rojo-Leyva F. Ratliff NB. Cosgrove DM 3rd. Hoffman GS. Study of 52 patients with idiopathic aortitis from a cohort of 1.204 surgical cases. Arthritis Rheum. 2000;43:901-907.
24. Fujikawa S. Okuni M. A nationwide surveillance study of rheumatic diseases among Japanese children. Acta Paediatr Jpn. 1997;39:242-244.
25. Salvarani C. Crowson CS. O'Fallon WM. Hunder GG. Gabriel SE. Reappraisal of the epidemiology of giant cell arteritis in Olmsted County. Minnesota. over a fifty-year period. Arthritis Rheum. 2004;51: 264-268.
26. Nordborg C. Johansson H. Petursdottir V. Nordborg E. The epidemiology of biopsy-positive giant cell arteritis: special reference to changes in the age of the population. Rheumatology (Oxford). 2003;42:549-552.
27. Lane SE. Watts R. Scott DG. Epidemiology of systemic vasculitis. Curr Rheumatol Rep. 2005;7:270-275.
28. Salvarani C. Macchioni P. Zizzi F. Mantovani W. Rossi F. Castri C. Capozzoli N. Baricchi R. Boiardi L. Chiaravalloti F. Portioli I. Epide-miologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy. Arthritis Rheum. 1991;34:351-356.
29. Gonzalez-Gay MA. Garcia-Porrua C. Rivas MJ. Rodriguez-Ledo P. Llorca J. Epidemiology of biopsy proven giant cell arteritis in north western Spain: trend over an 18 year period. Ann Rheum Dis. 2001;60: 367-371.
30. Sonnenblick M. Nesher G. Friedlander Y. Rubinow A. Giant cell arteritis in Jerusalem: a 12-year epidemiological study. Br J Rheumatol. 1994;33:938 -941.
31. Gonzalez EB. Varner WT. Lisse JR. Daniels JC. Hokanson JA. Giant-cell arteritis in the southern United States: an 11-year retrospective study from the Texas Gulf Coast. Arch Intern Med. 1989;149: 1561-1565.
32. Kobayashi S. Yano T. Matsumoto Y. Numano F. Nakajima N. Yasuda K. Yutani C. Nakayama T. Tamakoshi A. Kawamura T. Ohno Y. Inaba Y. Hashimoto H. Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: the first government-supported nationwide survey. Arthritis Rheum. 2003;49: 594-598.
33. Hall S. Barr W. Lie JT. Stanson AW. Kazmier FJ. Hunder GG. Takayasu arteritis: a study of 32 North American patients. Medicine (Baltimore). 1985;64:89-99.
34. Reinhold-Keller E. Herlyn K. Wagner-Bastmeyer R. Gross WL. Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum. 2005;53:93-99.
35. Koide K. Takayasu arteritis in Japan. Heart Vessels Suppl. 1992;7: 48 -54.
36. Nuenninghoff DM. Hunder GG. Christianson TJ. McClelland RL. Matteson EL. Incidence and predictors of large-artery complication (aortic aneurysm. aortic dissection. and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum. 2003;48:3522-3531.
37. Evans JM. O'Fallon WM. Hunder GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis: a population-based study. Ann Intern Med. 1995;122:502-507.
38. Silver AS. Shao CY. Ginzler EM. Aortitis and aortic thrombus in systemic lupus erythematosus. Lupus. 2006;15:541-543.
39. Vaideeswar P. Deshpande JR. Non-atherosclerotic aorto-arterial thrombosis: a study of 30 cases at autopsy. J Postgrad Med. 2001;47:8-14.
40. Hunder GG. Bloch DA. Michel BA. Stevens MB. Arend WP. Calabrese LH. Edworthy SM. Fauci AS. Leavitt RY. Lie JT. Lightfoot RW Jr. Masi AT. McShane DJ. Mills JA. Wallace SL. Zvaifler NJ. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33:1122-1128.
41. Salvarani C. Cantini F. Boiardi L. Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med. 2002;347:261-271.
42. Tato F. Hoffmann U. Clinical presentation and vascular imaging in giant cell arteritis of the femoropopliteal and tibioperoneal arteries. Analysis of four cases. J Vasc Surg. 2006;44:176-182.
43. Jang JJ. Gorevic PD. Olin JW. Images in vascular medicine: giant cell arteritis presenting with acute myocardial infarction. Vasc Med. 2007; 12:379.
44. Kerr GS. Hallahan CW. Giordano J. Leavitt RY. Fauci AS. Rottem M. Hoffman GS. Takayasu arteritis. Ann Intern Med. 1994;120:919 -929.
45. Mwipatayi BP. Jeffery PC. Beningfield SJ. Matley PJ. Naidoo NG. Kalla AA. Kahn D. Takayasu arteritis: clinical features and management: report of 272 cases. ANZ J Surg. 2005;75:110-117.
46. Park MC. Lee SW. Park YB. Chung NS. Lee SK. Clinical characteristics and outcomes of Takayasu's arteritis: analysis of 108 patients using standardized criteria for diagnosis. activity assessment. and angio-graphic classification. Scand J Rheumatol. 2005;34:284-292.
47. Arend WP. Michel BA. Bloch DA. Hunder GG. Calabrese LH. Edworthy SM. Fauci AS. Leavitt RY. Lie JT. Lightfoot RW Jr. Masi AT. McShane DJ. Mills JA. Stevens MB. Wallace SL. Zvaifler NJ. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990;33:1129 -1134.
48. Sueyoshi E. Sakamoto I. Hayashi K. Aortic aneurysms in patients with Takayasu's arteritis: CT evaluation. AJR Am J Roentgenol. 2000;175: 1727-1733.
49. Matsumura K. Hirano T. Takeda K. Matsuda A. Nakagawa T. Yamaguchi N. Yuasa H. Kusakawa M. Nakano T. Incidence of aneu-rysms in Takayasu's arteritis. Angiology. 1991;42:308-315.
50. Miyata T. Sato O. Koyama H. Shigematsu H. Tada Y. Long-term survival after surgical treatment of patients with Takayasu's arteritis. Circulation. 2003;108:1474-1480.
51. Kang WC. Han SH. Oh KJ. Ahn TH. Shin EK. Images in cardiovascular medicine: implantation of a drug-eluting stent for the coronary artery stenosis of Takayasu arteritis: de novo and in-stent restenosis. Circulation. 2006;113:e735-e737.
52. Lie JT. Isolated pulmonary Takayasu arteritis: clinicopathologic characteristics. Mod Pathol. 1996;9:469-474.
53. Liu YQ. Jin BL. Ling J. Pulmonary artery involvement in aortoarteritis: an angiographic study. Cardiovasc Intervent Radiol. 1994;17:2-6.
54. Yamada I. Shibuya H. Matsubara O. Umehara I. Makino T. Numano F. Suzuki S. Pulmonary artery disease in Takayasu's arteritis: angiographic findings. AJR Am J Roentgenol. 1992;159:263-269.
55. Sharma S. Kamalakar T. Rajani M. Talwar KK. Shrivastava S. The incidence and patterns of pulmonary artery involvement in Takayasu's arteritis. Clin Radiol. 1990;42:177-181.
56. He NS. Liu F. Wu EH. Zhang CL. Yang JG. Tan J. Gao S. Yang LC. Zhou YB. Pulmonary artery involvement in aorto-arteritis: an analysis of DSA. Chin Med J (Engl). 1990;103:666-672.
57. Zeina AR. Gleb S. Naschitz JE. Loberman Z. Barmeir E. Isolated periaortitis: clinical and imaging characteristics. Vasc Health Risk Manag. 2007;3:1083-1086.
58. Lance NJ. Levinson DJ. Aortitis and periaortic fibrosis. J Rheumatol. 1991;18:1095-1099.
59. Bardin JA. Collins GM. Devin JB. Halasz NA. Nonaneurysmal suppu- rative aortitis. Arch Surg. 1981;116:954-956.
60. Fernandez Guerrero ML. Aguado JM. Arribas A. Lumbreras C. de Gorgolas M. The spectrum of cardiovascular infections due to Salmonella enterica: a review of clinical features and factors determining outcome. Medicine (Baltimore). 2004;83:123-138.
61. Muller BT. Wegener OR. Grabitz K. Pillny M. Thomas L. Sandmann W. Mycotic aneurysms of the thoracic and abdominal aorta and iliac arteries: experience with anatomic and extra-anatomic repair in 33 cases. J Vasc Surg. 2001;33:106-113.
62. Reddy DJ. Shepard AD. Evans JR. Wright DJ. Smith RF. Ernst CB. Management of infected aortoiliac aneurysms. Arch Surg. 1991;126: 873-878.
63. Gajaraj A. Victor S. Tuberculous aortoarteritis. Clin Radiol. 1981;32: 461-466.
64. Kissin EY. Merkel PA. Diagnostic imaging in Takayasu arteritis. Curr Opin Rheumatol. 2004;16:31-37.
65. Takahashi T. Ando M. Okita Y. Tagusari O. Hanabusa Y. Kitamura S. Redo aortic valve replacement with "porcelain" aorta in an aortitis patient: a case report. J Cardiovasc Surg (Torino). 2005;46:77-79.
66. Tso E. Flamm SD. White RD. Schvartzman PR. Mascha E. Hoffman GS. Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum. 2002;46: 1634 -1642.
67. Flamm SD. White RD. Hoffman GS. The clinical application of "edema-weighted" magnetic resonance imaging in the assessment of Takayasu's arteritis. Int J Cardiol. 1998;66(suppl 1):S151-S159.
68. Bley TA. Ness T. Warnatz K. Frydrychowicz A. Uhl M. Hennig J. Langer M. Markl M. Influence of corticosteroid treatment on MRI findings in giant cell arteritis. Clin Rheumatol. 2007;26:1541-1543.
69. Meller J. Strutz F. Siefker U. Scheel A. Sahlmann CO. Lehmann K. Conrad M. Vosshenrich R. Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging. 2003;30: 730-736.
70. Kobayashi Y. Ishii K. Oda K. Nariai T. Tanaka Y. Ishiwata K. Numano F. Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT. J Nucl Med. 2005;46: 917-922.
71. Meller J. Grabbe E. Becker W. Vosshenrich R. Value of F-18 FDG hybrid camera PET and MRI in early Takayasu aortitis. Eur Radiol. 2003;13:400-405.
72. Webb M. Chambers A. Al-Nahhas A. Mason JC. Maudlin L. Rahman L. Frank J. The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging. 2004;31:627-634.
73. Walter MA. Melzer RA. Schindler C. Muller-Brand J. Tyndall A. Nitzsche EU. The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging. 2005;32:674-681.
74. Soto ME. Espinola-Zavaleta N. Ramirez-Quito O. Reyes PA. Echocar-diographic follow-up of patients with Takayasu's arteritis: five-year survival. Echocardiography. 2006;23:353-360.
75. Harris KM. Malenka DJ. Plehn JF. Transesophageal echocardiographic evaluation of aortitis. Clin Cardiol. 1997;20:813-815.
76. Tsui KL. Lee KW. Chan WK. Chan HK. Hon SF. Leung TC. Lee KL. Tsoi TH. Li SK. Behcet's aortitis and aortic regurgitation: a report of two cases. J Am Soc Echocardiogr. 2004;17:83-86.
77. Schmidt WA. Kraft HE. Vorpahl K. Volker L. Gromnica-Ihle EJ. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med. 1997;337:1336-1342.
78. LeSar CJ. Meier GH. DeMasi RJ. Sood J. Nelms CR. Carter KA. Gayle RG. Parent FN. Marcinczyk MJ. The utility of color duplex ultra-sonography in the diagnosis of temporal arteritis. J Vasc Surg. 2002;36: 1154-1160.
79. Schmidt WA. Technology insight: the role of color and power Doppler ultrasonography in rheumatology. Nat Clin Pract Rheumatol. 2007;3: 35-42.
80. Agard C. Hamidou MA. Said L. Ponge T. Connault J. Chevalet P. Masseau A. Pistorius MA. Brisseau JM. Planchon B. Barrier JH. Screening of abdominal aortic involvement using Doppler sonography in active giant cell (temporal) arteritis at the time of diagnosis: a prospective study of 30 patients [in French]. Rev Med Interne. 2007;28: 363-370.
81. Maeda H. Handa N. Matsumoto M. Hougaku H. Ogawa S. Oku N. Itoh T. Moriwaki H. Yoneda S. Kimura K. Kamada T. Carotid lesions detected by B-mode ultrasonography in Takayasu's arteritis: "macaroni sign" as an indicator of the disease. Ultrasound Med Biol. 1991;17: 695-701.
82. Buckley A. Southwood T. Culham G. Nadel H. Malleson P. Petty R. The role of ultrasound in evaluation of Takayasu's arteritis. J Rheumatol. 1991;18:1073-1080.
83. Lefebvre C. Rance A. Paul JF. Beguin C. Bletry O. Amoura Z. Piette JC. Fiessinger JN. The role of B-mode ultrasonography and electron beam computed tomography in evaluation of Takayasu's arteritis: a study of 43 patients. Semin Arthritis Rheum. 2000;30:25-32.
84. Sun Y. Yip PK. Jeng JS. Hwang BS. Lin WH. Ultrasonographic study and long-term follow-up of Takayasu's arteritis. Stroke. 1996;27: 2178-2182.
85. Raninen RO. Kupari MM. Pamilo MS. Pajari RI. Poutanen VP. Hekali PE. Arterial wall thickness measurements by B mode ultrasonography in patients with Takayasu's arteritis. Ann Rheum Dis. 1996;55:461-465.
86. Fukudome Y. Abe I. Onaka U. Fujii K. Ohya Y. Fukuhara M. Kaseda S. Esaki M. Fujishima M. Regression of carotid wall thickening after corticosteroid therapy in Takayasu's arteritis evaluated by B-mode ultra-sonography: report of 2 cases. J Rheumatol. 1998;25:2029 -2032.
87. Seth S. Goyal NK. Jagia P. Gulati G. Karthikeyan G. Sharma S. Talwar KK. Carotid intima-medial thickness as a marker of disease activity in Takayasu's arteritis. Int J Cardiol. 2006;108:385-390.
88. Salvarani C. Cantini F. Boiardi L. Hunder GG. Laboratory investigations useful in giant cell arteritis and Takayasu's arteritis. Clin Exp Rheumatol. 2003;21:S23-S28.
89. Hoffman GS. Ahmed AE. Surrogate markers of disease activity in patients with Takayasu arteritis: a preliminary report from the International Network for the Study of the Systemic Vasculitides (INSSYS). Int J Cardiol. 1998;66(suppl 1):S191-S194.
90. Park MC. Lee SW. Park YB. Lee SK. Serum cytokine profiles and their correlations with disease activity in Takayasu's arteritis. Rheumatology (Oxford). 2006;45:545-548.
91. Matsuyama A. Sakai N. Ishigami M. Hiraoka H. Kashine S. Hirata A. Nakamura T. Yamashita S. Matsuzawa Y. Matrix metalloproteinases as novel disease markers in Takayasu arteritis. Circulation. 2003;108: 1469 -1473.
92. Jarrett F. Darling RC. Mundth ED. Austen WG. The management of infected arterial aneurysms. J Cardiovasc Surg (Torino). 1977;18: 361-366.
93. Oskoui R. Davis WA. Gomes MN. Salmonella aortitis: a report of a successfully treated case with a comprehensive review of the literature. Arch Intern Med. 1993;153:517-525.
94. Soravia-Dunand VA. Loo VG. Salit IE. Aortitis due to Salmonella: report of 10 cases and comprehensive review of the literature. Clin Infect Dis. 1999;29:862-868.
95. Krohg-Sorensen K. Hafsahl G. Fosse E. Geiran OR. Acceptable short-term results after endovascular repair of diseases of the thoracic aorta in high risk patients. Eur J Cardiothorac Surg. 2003;24:379-387.
96. Chan YC. Morales JP. Taylor PR. The management of mycotic aortic aneurysms: is there a role for endoluminal treatment? Acta Chir Belg. 2005;105:580-587.
97. Stanley BM. Semmens JB. Lawrence-Brown MM. Denton M. Grosser D. Endoluminal repair of mycotic thoracic aneurysms. J Endovasc Ther. 2003;10:511-515.
98. Semba CP. Sakai T. Slonim SM. Razavi MK. Kee ST. Jorgensen MJ. Hagberg RC. Lee GK. Mitchell RS. Miller DC. Dake MD. Mycotic aneurysms of the thoracic aorta: repair with use of endovascular stent-grafts. J Vasc Interv Radiol. 1998;9:33-40.
99. Koening CL. Langford CA. Takayasu's arteritis. Curr Treat Options Cardiovasc Med. 2008;10:164-172.
100. Proven A. Gabriel SE. Orces C. O'Fallon WM. Hunder GG. Glucocor- ticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum. 2003;49:703-708.
101. Hachulla E. Boivin V. Pasturel-Michon U. Fauchais AL. Bouroz-Joly J. Perez-Cousin M. Hatron PY. Devulder B. Prognostic factors and long-term evolution in a cohort of 133 patients with giant cell arteritis. Clin Exp Rheumatol. 2001;19:171-176.
102. Maksimowicz-McKinnon K. Clark TM. Hoffman GS. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum. 2007;56:1000-1009.
103. Recommendations for the prevention and treatment of glucocorticoid- induced osteoporosis: 2001 update: American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis. Arthritis Rheum. 2001;44:1496-1503.
104. Nesher G. Sonnenblick M. Friedlander Y. Analysis of steroid related complications and mortality in temporal arteritis: a 15-year survey of 43 patients. J Rheumatol. 1994;21:1283-1286.
105. Danesh-Meyer H. Savino PJ. Gamble GG. Poor prognosis of visual outcome after visual loss from giant cell arteritis. Ophthalmology. 2005; 112:1098 -1103.
106. Chan CC. Paine M. O'Day J. Steroid management in giant cell arteritis. Br J Ophthalmol. 2001;85:1061-1064.
107. Hunder GG. Sheps SG. Allen GL. Joyce JW. Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis: comparison in a prospective study. Ann Intern Med. 1975;82:613-618.
108. Mazlumzadeh M. Hunder GG. Easley KA. Calamia KT. Matteson EL. Griffing WL. Younge BR. Weyand CM. Goronzy JJ. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind. placebo-controlled. randomized prospective clinical trial. Arthritis Rheum. 2006;54:3310-3318.
109. Hoffman GS. Cid MC. Hellmann DB. Guillevin L. Stone JH. Schousboe J. Cohen P. Calabrese LH. Dickler H. Merkel PA. Fortin P. Flynn JA. Locker GA. Easley KA. Schned E. Hunder GG. Sneller MC. Tuggle C. Swanson H. Hernandez-Rodriguez J. Lopez-Soto A. Bork D. Hoffman DB. Kalunian K. Klashman D. Wilke WS. Scheetz RJ. Mandell BF. Fessler BJ. Kosmorsky G. Prayson R. Luqmani RA. Nuki G. McRorie E. Sherrer Y. Baca S. Walsh B. Ferland D. Soubrier M. Choi HK. Gross W. Segal AM. Ludivico C. Puechal X. A multicenter. randomized. double-blind. placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum. 2002;46:1309-1318.
110. Jover JA. Hernandez-Garcia C. Morado IC. Vargas E. Banares A. Fernandez-Gutierrez B. Combined treatment of giant-cell arteritis with methotrexate and prednisone: a randomized. double-blind. placebo- controlled trial. Ann Intern Med. 2001;134:106-114.
111. Spiera RF. Mitnick HJ. Kupersmith M. Richmond M. Spiera H. Peterson MG. Paget SA. A prospective. double-blind. randomized. placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA). Clin Exp Rheumatol. 2001;19:495-501.
112. Hoffman GS. Cid MC. Rendt-Zagar KE. Merkel PA. Weyand CM. Stone JH. Salvarani C. Xu W. Visvanathan S. Rahman MU. Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. Ann Intern Med. 2007;146:621-630.
113. Koening CL. Langford CA. Novel therapeutic strategies for large vessel vasculitis. Rheum Dis Clin North Am. 2006;32:173-186. xi.
114. Hoffman GS. Leavitt RY. Kerr GS. Rottem M. Sneller MC. Fauci AS. Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum. 1994;37:578-582.
115. Valsakumar AK. Valappil UC. Jorapur V. Garg N. Nityanand S. Sinha N. Role of immunosuppressive therapy on clinical. immunological. and angiographic outcome in active Takayasu's arteritis. J Rheumatol. 2003; 30:1793-1798.
116. Hoffman GS. Merkel PA. Brasington RD. Lenschow DJ. Liang P. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum. 2004;50:2296-2304.
117. Shinjo SK. Pereira RM. Tizziani VA. Radu AS. Levy-Neto M. Myco- phenolate mofetil reduces disease activity and steroid dosage in Takayasu arteritis. Clin Rheumatol. 2007;26:1871-1875.
118. Gornik HL. Creager MA. Diseases of the aorta. In: Topol EJ. ed. Textbook ofCardiovascular Medicine. 3rd ed. Philadelphia. Pa: Lip-pincott. Williams &Wilkins; 2007.
119. Zehr KJ. Mathur A. Orszulak TA. Mullany CJ. Schaff HV. Surgical treatment of ascending aortic aneurysms in patients with giant cell aortitis. Ann Thorac Surg. 2005;79:1512-1517.
120. Engelke C. Sandhu C. Morgan RA. Belli AM. Endovascular repair of thoracic aortic aneurysm and intramural hematoma in giant cell arteritis. J Vasc Interv Radiol. 2002;13:625-629.
121. Baril DT. Carroccio A. Palchik E. Ellozy SH. Jacobs TS. Teodorescu V. Marin ML. Endovascular treatment of complicated aortic aneurysms in patients with underlying arteriopathies. Ann Vasc Surg. 2006;20: 464-471.
122. D'Souza SJ. Tsai WS. Silver MM. Chait P. Benson LN. Silverman E. Hebert D. Balfe JW. Diagnosis and management of stenotic aorto-arteriopathy in childhood. J Pediatr. 1998;132:1016-1022.
123. Tyagi S. Kaul UA. Arora R. Endovascular stenting for unsuccessful angioplasty of the aorta in aortoarteritis. Cardiovasc Intervent Radiol. 1999;22:452-456.
124. Bali HK. Jain S. Jain A. Sharma BK. Stent supported angioplasty in Takayasu arteritis. Int J Cardiol. 1998;66(suppl 1):S213-S217.
125. Liang P. Tan-Ong M. Hoffman GS. Takayasu's arteritis: vascular interventions and outcomes. J Rheumatol. 2004;31:102-106.
126. Delis KT. Gloviczki P. Middle aortic syndrome: from presentation to contemporary open surgical and endovascular treatment. Perspect Vasc Surg Endovasc Ther. 2005;17:187-203.
127. Monte R. Gonzalez-Gay MA. Garcia-Porrua C. Lopez-Alvarez MJ. Pulpeiro JR. Successful response to angioplasty in a patient with upper limb ischaemia secondary to giant cell arteritis. Br J Rheumatol. 1998; 37:344.
128. Both M. Aries PM. Muller-Hulsbeck S. Jahnke T. Schafer PJ. Gross WL. Heller M. Reuter M. Balloon angioplasty of arteries of the upper extremities in patients with extracranial giant-cell arteritis. Ann Rheum Dis. 2006;65:1124-1130.